TRVI
$12.83+7.82%
Trevi Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.002% of IWV
Trevi Therapeutics Inc. monthly returns
Trevi Therapeutics Inc. has averaged 6.03% per month, positive in 45% of months. Month-by-month returns for Trevi Therapeutics Inc. (TRVI) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+6.0%
82 months
Best month
+243.8%
Mar 2022
Worst month
-51.6%
Sep 2022
Positive months
45%
of all months
Trevi Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -10.4% | |
| Sep 2026 | -13.7% | |
| Aug 2026 | -9.0% | |
| Jul 2026 | -2.1% | |
| Jun 2026 | +31.9% | |
| May 2026 | +2.8% | |
| Apr 2026 | +15.3% | |
| Mar 2026 | +0.1% | |
| Feb 2026 | +13.8% | |
| Jan 2026 | -16.4% | |
| Dec 2025 | -5.1% | |
| Nov 2025 | +13.1% | |
| Oct 2025 | +27.4% | |
| Sep 2025 | +26.1% | |
| Aug 2025 | -2.0% | |
| Jul 2025 | +35.4% | |
| Jun 2025 | -16.0% | |
| May 2025 | -5.8% | |
| Apr 2025 | +9.9% | |
| Mar 2025 | +39.2% | |
| Feb 2025 | +14.7% | |
| Jan 2025 | -4.4% | |
| Dec 2024 | +43.1% | |
| Nov 2024 | -2.2% | |
| Oct 2024 | -11.8% | |
| Sep 2024 | +5.7% | |
| Aug 2024 | -0.6% | |
| Jul 2024 | +6.7% | |
| Jun 2024 | +16.0% | |
| May 2024 | -12.3% | |
| Apr 2024 | -15.1% | |
| Mar 2024 | +18.2% | |
| Feb 2024 | +105.6% | |
| Jan 2024 | +6.0% | |
| Dec 2023 | +19.1% | |
| Nov 2023 | -36.8% | |
| Oct 2023 | -18.3% | |
| Sep 2023 | -1.4% | |
| Aug 2023 | -7.1% | |
| Jul 2023 | -0.4% | |
| Jun 2023 | +10.6% | |
| May 2023 | -37.2% | |
| Apr 2023 | +85.9% | |
| Mar 2023 | -22.6% | |
| Feb 2023 | +2.6% | |
| Jan 2023 | +20.7% | |
| Dec 2022 | +2.7% | |
| Nov 2022 | -5.1% | |
| Oct 2022 | +28.6% | |
| Sep 2022 | -51.6% | |
| Aug 2022 | +3.9% | |
| Jul 2022 | +8.9% | |
| Jun 2022 | +16.1% | |
| May 2022 | -10.4% | |
| Apr 2022 | +22.7% | |
| Mar 2022 | +243.8% | |
| Feb 2022 | +0.3% | |
| Jan 2022 | -18.4% | |
| Dec 2021 | -21.4% | |
| Nov 2021 | -15.3% | |
| Oct 2021 | -16.1% | |
| Sep 2021 | -15.7% | |
| Aug 2021 | -12.6% | |
| Jul 2021 | -15.6% | |
| Jun 2021 | +5.6% | |
| May 2021 | -7.0% | |
| Apr 2021 | -15.5% | |
| Mar 2021 | -3.9% | |
| Feb 2021 | -5.4% | |
| Jan 2021 | +23.1% | |
| Dec 2020 | -20.7% | |
| Nov 2020 | -5.3% | |
| Oct 2020 | -20.1% | |
| Sep 2020 | +0.0% | |
| Aug 2020 | -18.9% | |
| Jul 2020 | -24.5% | |
| Jun 2020 | +140.1% | |
| May 2020 | -4.5% | |
| Apr 2020 | -12.8% | |
| Mar 2020 | -36.6% | |
| Feb 2020 | +4.2% | |
| Jan 2020 | +32.8% | |
| Dec 2019 | +6.5% | |
| Nov 2019 | +19.3% | |
| Oct 2019 | -34.4% | |
| Sep 2019 | -9.3% | |
| Aug 2019 | -17.5% | |
| Jul 2019 | -19.9% | |
| Jun 2019 | -24.9% |
Monthly total return (since Nov 2021)#
-200%-100%0%100%200%
Nov 2021-15%
Dec 2021-21%
Jan 2022-18%2022
Feb 2022+0.31%
Mar 2022+244%
Apr 2022+23%
May 2022-10%
Jun 2022+16%
Jul 2022+8.9%
Aug 2022+3.9%
Sep 2022-52%
Oct 2022+29%
Nov 2022-5.1%
Dec 2022+2.7%
Jan 2023+21%2023
Feb 2023+2.6%
Mar 2023-23%
Apr 2023+86%
May 2023-37%
Jun 2023+11%
Jul 2023-0.42%
Aug 2023-7.1%
Sep 2023-1.4%
Oct 2023-18%
Nov 2023-37%
Dec 2023+19%
Jan 2024+6.0%2024
Feb 2024+106%
Mar 2024+18%
Apr 2024-15%
May 2024-12%
Jun 2024+16%
Jul 2024+6.7%
Aug 2024-0.63%
Sep 2024+5.7%
Oct 2024-12%
Nov 2024-2.2%
Dec 2024+43%
Jan 2025-4.4%2025
Feb 2025+15%
Mar 2025+39%
Apr 2025+9.9%
May 2025-5.8%
Jun 2025-16%
Jul 2025+35%
Aug 2025-2.0%
Sep 2025+26%
Oct 2025+27%
Nov 2025+13%
Dec 2025-5.1%
Jan 2026-16%2026
Feb 2026+14%
Mar 2026+0.08%
Apr 2026+15%
May 2026+2.8%
Jun 2026+32%
Jul 2026-2.1%
Aug 2026-9.0%
Sep 2026-14%
Oct 2026-10%
Trevi Therapeutics Inc. returns by calendar month#
Every month of every year since 2020, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -10.41% — 3rd of 7 Octobers since 2020 at the last close; the average October returned -1.7%.
| Month | −245%0+245% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.2% | +6.0% | 57% | +32.8% 2020 | -18.4% 2022 | |
| Feb | +19.4% | +4.2% | 86% | +105.6% 2024 | -5.4% 2021 | |
| Mar | +34.0% | +0.1% | 57% | +243.8% 2022 | -36.6% 2020 | |
| Apr | +12.9% | +9.9% | 57% | +85.9% 2023 | -15.5% 2021 | |
| May | -10.6% | -7.0% | 14% | +2.8% 2026 | -37.2% 2023 | |
| Jun | +29.2% | +16.0% | 86% | +140.1% 2020 | -16.0% 2025 | |
| Jul | +1.2% | -0.4% | 43% | +35.4% 2025 | -24.5% 2020 | |
| Aug | -6.6% | -7.1% | 14% | +3.9% 2022 | -18.9% 2020 | |
| Sep | -7.2% | -1.4% | 29% | +26.1% 2025 | -51.6% 2022 | |
| Oct | -1.7% | -13.9% | 33% | +28.6% 2022 | -20.1% 2020 | |
| Nov | -8.6% | -5.2% | 17% | +13.1% 2025 | -36.8% 2023 | |
| Dec | +2.9% | -1.2% | 50% | +43.1% 2024 | -21.4% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from TRVI's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Trevi Therapeutics Inc.'s average monthly return?
- Trevi Therapeutics Inc. (TRVI) has averaged about 6.03% per month, positive in roughly 45% of months. The best month was Mar 2022 (+243.8%) and the worst was Sep 2022 (-51.6%).
More on Trevi Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100